OTC: HYOR
HyOrc CorpCIK 0001070789 · SIC 8711 · Engineering Services
We were incorporated in Nevada on April 6, 1998. Our principal executive offices are located at 119 N Commercial Street, Suite 190-115, Bellingham, Washington 98225. Our fiscal year end is December 31 and our shares are traded on the Pink Sheets under the symbol “ASPZ”. We are also listed in the… About this business →
Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.
Sign up freeWant to see a complete report first? Today's free report (LAC 10-Q) is open in full — no account needed.
Summary not yet generated.
Summary not yet generated.
Partner
Trade HYOR commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Summary not yet generated.
Latest financial statements
From 10-Q filed Aug 6, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.
Consolidated Statements of Operations (Unaudited)
| Description | Three months ended June 30, 2026 | Three months ended June 30, 2025 | Six months ended June 30, 2026 | Six months ended June 30, 2025 |
|---|---|---|---|---|
| Revenue | 24,000 | 0 | 24,000 | 150 |
| Gross profit | 24,000 | 0 | 24,000 | 150 |
| Other income | 0 | 11,559 | 0 | 11,559 |
| Total income | 24,000 | 11,559 | 24,000 | 11,709 |
| Administrative and other expenses | 374,059 | 70,972 | 458,719 | 94,187 |
| Interest expense | 108,092 | 0 | 108,092 | 0 |
| Loan Issuance Costs | 11,030 | 0 | 11,030 | 0 |
| (Gain) loss on change in fair value of derivative liability | (17,816) | 0 | (17,816) | 0 |
| Loss on issuance of convertible notes and commitment shares | 238,347 | 0 | 238,347 | 0 |
| Total expenses | 713,712 | 70,972 | 798,372 | 94,187 |
| Net loss for the period | (689,712) | (59,413) | (774,372) | (82,478) |
Consolidated Balance Sheets (Unaudited)
| Description | June 30, 2026 | December 31, 2025 |
|---|---|---|
| ASSETS | ||
| Current Assets: | ||
| Cash and cash equivalents | 53,912 | 19,417 |
| Trade receivable, net | 36,541 | 36,541 |
| Total current assets | 90,453 | 55,958 |
| Plant and equipment | 2,483,776 | 2,320,000 |
| Patents | 3,604,558 | 3,604,558 |
| Goodwill | 15,755,344 | 15,755,344 |
| Investment in subsidiary | 0 | 0 |
| Total non-current assets | 21,843,678 | 21,679,902 |
| TOTAL ASSETS | 21,934,131 | 21,735,860 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Trade payable | 95,711 | 15,000 |
| Subscription money advance | 55,000 | 0 |
| Convertible notes payable, net of discount | 108,092 | 0 |
| Derivative liability | 466,556 | 0 |
| Total current liabilities | 725,359 | 15,000 |
| Total liabilities | 725,359 | 15,000 |
| Stockholders’ equity: | ||
| Common stock | 740,035 | 737,090 |
| Common stock issuable | 17,975 | 0 |
| Additional paid-in capital | 29,886,727 | 29,645,364 |
| Common stock subscribed | 105,941 | 105,941 |
| Accumulated deficit | (9,541,906) | (8,767,534) |
| Total stockholders’ equity | 21,208,771 | 21,720,860 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | 21,934,131 | 21,735,860 |
Consolidated Statements of Cash Flows (Unaudited)
| Description | 2026 | 2025 |
|---|---|---|
| Net loss for the period | (774,372) | (82,478) |
| Amortization of debt discount (non-cash) | 108,092 | 0 |
| (Gain) loss on change in fair value of derivative liability (non-cash) | (17,816) | 0 |
| Loss on issuance of convertible notes and commitment shares (non-cash) | 238,347 | 0 |
| Lender legal and transaction costs (non-cash withheld at closing) | 11,030 | 0 |
| Movements in working capital: | ||
| Subscription money advance | 55,000 | 0 |
| Trade payable | 80,711 | (160,167) |
| Trade receivable | 0 | (70) |
| Intercompany balances | 0 | 0 |
| Net cash provided by (used in) operating activities | (299,008) | (242,716) |
| Cash flows from investing activities | ||
| Investment in subsidiary | 0 | 0 |
| Purchase of plant and equipment | (163,776) | 0 |
| Net cash provided by (used in) investing activities | (163,776) | 0 |
| Cash flows from financing activities | ||
| Proceeds from issuance of convertible notes, net of costs withheld [1] | 252,970 | 0 |
| Proceeds from issuance of common stock | 244,308 | 113,350 |
| Net cash provided by (used in) financing activities | 497,278 | 113,350 |
| Net increase (decrease) in cash and cash equivalents | 34,495 | (129,366) |
| Cash and cash equivalents at January 1, | 19,417 | 176,016 |
| Cash and cash equivalents at June 30, | 53,912 | 46,650 |
Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗
About HyOrc Corp
Source: Item 1 (Business) from the 10-K filed November 9, 2017. Description as filed by the company with the SEC.
ITEM
1. BUSINESS
General
We
were incorporated in Nevada on April 6, 1998. Our principal executive offices are located at 119 N Commercial Street, Suite 190-115,
Bellingham, Washington 98225. Our fiscal year end is December 31 and our shares are traded on the Pink Sheets under the symbol
“ASPZ”. We are also listed in the Mergent Manuals and News Reports.
Industry
Asia
Properties, Inc (the Company”) was established to seek opportunities to invest in real estate.
Our
Planned Operations
We
intend to acquire and seek opportunities to invest in real estate.
Website
We
currently maintain a website at www.aspz-usa.com.
Revenues
Currently
we have no revenue generating assets.
Employees
We
administer our business through consulting arrangements with our company’s officers, directors, other individuals and one
full-time employee.
Offices
We
maintain two offices, one at 119 N Commercial Street, Suite 190-115, Bellingham, Washington 98225, telephone number (360) 392-2841.
Our
second office is at Two Exchange Square, 8th Floor, 8 Connaught Place, Central, Hong Kong, a shared serviced office
leased from The Executive Centre.
4